Figures
- Figure 1.
Chest computed tomography scan from a 55-year-old male with pleuroparenchymal fibroelastosis (case 2) at the level of the 6th thoracic vertebra a) on admission and b) 5.27 years later. The anteroposterior diameter of the thoracic cage (APDT)/transverse diameter of the thoracic cage (TDT) ratio decreased after 5.27 years. Note the space present between the anterior edge of the ascending aorta and the anterior chest wall in (a). The anterior edge of the ascending aorta was attached to the anterior chest wall after 5.27 years. TDT was determined as the longest transverse diameter of the thoracic cage measured parallel to a line (#) that runs along the rearmost points of the bilateral 6th ribs in the horizontal section of the CT.
Tables
- Table 1. Change of the thoracic cage and forced vital capacity (FVC) in patients with pleuroparenchymal fibroelastosis
Case Age years Sex Idiopathic or with underlying disease Diagnostic method APDT/TDT ratio FVC (% predicted) 1st measurement 2nd measurement Interval between measurements 1st measurement 2nd measurement Interval between measurements 1 41 M Ulcerative colitis SLB 0.45 0.458 4.39 years 2 55 M Idiopathic SLB 0.592 0.509 5.27 years 3540 mL (87%) 1120 mL (29%) 4.67 years 3 60 M Idiopathic SLB 0.599 0.554 2.79 years 2580 mL (78%) 1040 mL (32%) 2.64 years 4 78 M Radiation therapy for oesophageal cancer Autopsy 0.579 0.53 1.87 years 2480 mL (69%) 1370 mL (39%) 1.42 years 5 32 F Lung transplantation SLB 0.54 0.489 2.31 years 2050 mL (69%) 640 mL (20%) 2.47 years 6 48 F Idiopathic SLB 0.599 0.522 4.03 years 2030 mL (67%) 1380 mL (49%) 3.61 years 7 59 F Idiopathic SLB 0.652 0.6 4.59 years 8 81 F Idiopathic Autopsy 0.729 0.612 2.04 years 1800 mL (83%) 1060 mL (51%) 1.84 years APDT: anteroposterior diameter of the thoracic cage; TDT: transverse diameter of the thoracic cage; M: male; F: female; SLB: surgical lung biopsy.
